From: Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population
Pulmonary involvement | 1st IgG test | 2nd IgG test | |||||
---|---|---|---|---|---|---|---|
N | Reactive n (%) | Nonreactive n (%) | p* | Persistent n (%) | Nonpersistent n (%) | p* | |
Normal | 8 | 7 (11.9) | 1 (12.5) | 0.05 | 3 (5.9) | 5 (31.2) | 0.02 |
Mild (< 25%) | 38 | 31 (52.5) | 7 (87.5) | 29 (56.9) | 9 (56.3) | ||
Moderate/severe (25 to 50%/> 50%) | 21 | 21 (35.6) | 0 (0.0) | 19 (37.2) | 2 (12.5) |